Clinical Trial

Evaluation of a Medical Device Based on Isotonic Seawater and Hyaluronic Acid Used as a Nasal Spray

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 8, 2025 (before its estimated January 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to see whether the nasal spray can help improve hydration of the nasal mucosa, reduce discomfort linked to nasal dryness, and confirm its safety in patients suffering from nasal dryness.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-30.
Trial Details
NCT Number NCT07204158
Lead Sponsor YSLab
Collaborators: Eclevar Medtech
Conditions Nasal Dryness
Enrollment 65 participants
Start Date 2025-10-07
Primary Completion 2026-01-30 (estimated)
Study Completion 2026-02-28 (estimated)
Updated on ClinicalTrials.gov 2025-10-08